Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Oscillin and MAbs against it offered for licensing

Dec. 17, 1996

New bile acid transporter inhibitors in preclinical testing at Searle

Dec. 16, 1996

Alanex and Novo Nordisk expand diabetes research collaboration

Dec. 16, 1996

Human growth hormone products recommended for approval

Dec. 16, 1996

Oral butyrate prodrug in preclinical testing at Vertex

Dec. 13, 1996

Encouraging clinical results with MacroChem Rx for impotence

Dec. 13, 1996

Chugai reports new cholesterol-lowering compounds

Dec. 13, 1996

Novel dual-action compounds described by Abbott

Dec. 12, 1996

New hypolipidemic agents claimed by Janssen

Dec. 12, 1996

Scotia drug shows excellent activity in cancer patients with cachexia

Dec. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...